Background:

While the associations between individual lifestyle factors and risk of hepatocellular carcinoma (HCC) have been described previously, their combined impact on HCC risk is unknown.

Methods:

The association of a composite score of healthy lifestyle factors, including body mass index, alcohol consumption, cigarette smoking, alternative Mediterranean diet, and sleep duration, and HCC risk was examined in the Singapore Chinese Health Study, an ongoing prospective cohort study of 63,257 Chinese men and women. Cox proportional hazard regression method was used to estimate HR and its 95% confidence interval (CI). Conditional logistic regression method was used to evaluate this composite lifestyle score–HCC risk association among a subset of individuals who tested negative for hepatitis B surface antigen (HBsAg) and anti–hepatitis C antibody.

Results:

After a mean follow-up of 17.7 years, 561 participants developed HCC. Individuals with higher composite scores representing healthier lifestyles (range 0–8) were at significantly lower risk of HCC. Compared with the lowest composite score category (0–4), the HRs (95% CIs) for the composite scores of 5, 6, 7, and 8 were 0.67 (0.62–0.85), 0.61 (0.48–0.77), 0.49 (0.37–0.65), and 0.13 (0.06–0.30), respectively (Ptrend < 0.0001). A similar inverse association was observed in participants with negative HBsAg and anti–hepatitis C virus (HCV)-negative serology (HR, 0.38; 95% CI, 0.19–0.79; for the highest vs. the lowest category of the composite scores; Ptrend = 0.001).

Conclusions:

Healthy lifestyles protect against HCC development, especially for individuals without hepatitis B virus and HCV infections.

Impact:

This study highlights the importance of a comprehensive lifestyle modification strategy for HCC primary prevention.

This article is featured in Highlights of This Issue, p. 243

Primary liver cancer was ranked the sixth most commonly diagnosed cancer and fourth leading cause of cancer-related deaths worldwide in 2018 (1). Hepatocellular carcinoma (HCC) accounts for 85%–90% of all primary liver cancers (2). The established major risk factors for HCC are chronic infection with hepatitis B virus (HBV) and/or hepatitis C virus (HCV), excessive alcohol use, and dietary exposure to aflatoxin (3, 4). Approximately two-third of HCC cases are attributable to hepatitis B and/or C infection (5). In the United States, the incidence rate of liver cancer has been increasing by 3%–4% per year since the mid-1970s and was three times higher in the 2012–2016 period than in the 1975–1979 period (6). With the implementation of effective universal hepatitis B vaccination program and curative therapy for hepatitis C, it is expected that noninfectious modifiable risk factors, including obesity, alcohol intake, cigarette smoking, unhealthy diet, and/or physical inactivity, will become increasingly important in the development of HCC.

Prior studies have shown that unhealthy lifestyle factors, including high intake of alcohol, higher body mass index (BMI), cigarette smoking, a diet with high red/processed meat and low fiber, and physical inactivity, are individually associated with higher risk of primary liver cancer or HCC (7–9). A recent analysis reported that longer duration of sleep was associated with moderately increased risk of primary liver cancer (10). Longer duration of sleep was also associated with an increased risk of nonalcoholic fatty liver disease (NAFLD), an emerging risk factor for HCC (11, 12). No study has examined the aggregated effect of these modifiable risk factors on the risk of developing HCC. Such data are important to support the development of comprehensive lifestyle modification programs for primary prevention of HCC. Therefore, we evaluated the association between the composite score of healthy lifestyle factors and the risk of HCC incidence in a population-based prospective cohort of more than 60,000 participants with up to 25 years of follow-up.

Study population

Data for this analysis were obtained from the Singapore Chinese Health Study, which was described in details elsewhere (13). Briefly, the Singapore Chinese Health Study is an ongoing population-based prospective cohort study that recruited 63,257 Chinese men and women, ages 45–74 years from two main dialect groups of Chinese in Singapore (i.e., Hokkiens and Cantonese) who resided in the government-built housing estates between April 1993 and December 1998. The Hokkiens and Cantonese were originated from the Fujian and Guangdong provinces in southern China, respectively. All study participants provided written informed consent. The Singapore Chinese Health Study is approved by the Institutional Review Boards of the National University of Singapore (Singapore) and the University of Pittsburgh (Pittsburgh, PA).

During the 1994–1999 period of recruitment, blood and urine samples were collected from a 3% random sample of the cohort. Between July 1999 and December 2003, all surviving study participants were reinterviewed by phone to update information on alcohol use, tobacco smoking, medical history, current physical activity, and body weight. Subsequently, they were asked to donate a blood (if declined, a mouthwash sample was collected instead) and urine sample for research use. Of all the subjects that we recontacted successfully, 28,346 subjects (∼57% of eligible participants) provided blood samples.

Assessment of lifestyle risk factors

At baseline, study participants were interviewed at home by trained interviewers who used a structured questionnaire to collect information on demographics, body weight and height, lifetime use of tobacco (cigarettes and water-pipe), current physical activity, occupational exposure, medical history, family history of cancer, menstrual and reproductive history (for women only), and dietary habits during the past 12 months. For cigarette smoking, subjects were first asked their smoking status (i.e., never, current, and former smokers). Former and current smokers were further asked for information on: (i) age of starting and age of quitting smoking, (ii) number of cigarettes per day, and (iii) number of years of smoking (14). For physical activity, the questionnaire listed the following categories: never, 0.5–1, 2–3, 4–6, 7–10, 11–20, 21–30, and 31 hours or more per week, for each of three physical activity categories: (i) strenuous sports (i.e., jogging, bicycling on hills, tennis, squash, swimming laps, or aerobics), (ii) vigorous work (i.e., moving heavy furniture, loading or unloading trucks, shoveling, or equivalent manual labor), and (iii) moderate activities (i.e., brisk walking, bowling, bicycling on level ground, tai chi, and chi kung; ref. 15). Sleep duration was evaluated using the following question: “on average, during the last year, how many hours in a day did you sleep?” with a response choice of six predefined categories: ≤5, 6, 7, 8, 9, and ≥10 hours per day.

Dietary intake was assessed using semiquantitative food frequency questionnaire (FFQ), which had been developed for and validated in the study population against a series of 24-hour dietary recall (24-HDR) interviews (16) and selected biomarkers studies (17, 18). The dietary questionnaire comprised 165 commonly consumed food and beverage items by Chinese Singaporeans. Study participants were asked how frequently they consumed the food or food groups in eight predefined categories, from “never or hardly ever” to “two or more times a day,” followed by predetermined portion sizes assisted with the illustration of food photos in an album. For alcohol consumption, each study participant was asked about his/her drinking frequency during the past year of four types of alcoholic beverages, beer, wine, Western hard liquor, and Chinese hard liquor, with a response choice of eight predefined categories for each type of beverage: never or hardly, once a month, 2–3 times a month, once a week, 2–3 times a week, 4–6 times a week, once a day, and ≥2 times a day. The portion size for each type of alcoholic beverage was defined as follows: (i) beer: ≤1 small bottle (375 mL), two small bottles or one large bottle (750 mL), and ≥3 large bottles; (ii) wine: ≤1 glass (118 mL), 2, 3, and ≥4 glasses; (iii) Western or Chinese hard liquor: ≤1 shot (30 mL), 2, 3, and ≥4 shots. Between April 1994 and March 1997, the FFQ was validated against two 24-HDRs, one on a weekday and the other on a weekend that was approximately 2 months apart, among a random sample of 810 participants of the Singapore Chinese Health Study. The correlation coefficients between the FFQ and 24-HDR for the majority of calorie-adjusted nutrients ranged from 0.24 to 0.79 (16).

Classification of the composite score of healthy lifestyle factors

The classification of the composite score of healthy lifestyle factors was based on their independent association with liver cancer or HCC (7–9, 19, 20). The lifestyle factors were alcohol consumption, cigarette smoking, dietary intake, and sleep duration, in addition to BMI. Alcohol consumption was categorized by the number of alcoholic drinks: one drink was defined as 375 mL of beer (13.6 grams of ethanol), 118 mL of wine (11.7 grams of ethanol), and 30 mL of Western or Chinese hard liquor (10.9 grams of ethanol; ref. 21). BMI was calculated as the current weight in kilograms divided by height in meters squared (kg/m2).

Alternative Mediterranean diet score

The previous studies have found an inverse association between dietary habits of Mediterranean populations and the risk of chronic diseases (22, 23). It originally included nine items (24). In our analysis, we included eight components: (i) vegetables, (ii) fruit and nuts, (iii) cereals, (iv) dairy, (v) legumes, (vi) fish, (vii) the ratio of monounsaturated fatty acid over saturated fatty acids, and (viii) meat and meat products after excluding alcohol (an independent risk factor; ref. 9). Each component was assigned a score of 0 or 1 according to the consumption level (below or above the study population–specific median) and healthy/unhealthy status of the component. The summed score of alternative Mediterranean diet (aMED) ranged from 0–8.

For BMI, we used the cutoff of 23 kg/m2, following both World Health Organization and the Asia-Pacific recommendations (25, 26). Individuals with BMI < 23 kg/m2 were assigned a lifestyle score of one, otherwise a score of zero. For alcohol consumption, zero was assigned to heavy drinker, defined as men who drank ≥15 drinks per week and women who drank ≥8 drinks per week, and one otherwise (i.e., to both nondrinker and nonheavy drinker group). For cigarette smoking, zero was assigned to heavy smokers (defined as those who started smoking before 15 years of age and smoked 13 or more cigarettes per day), one to the remaining light smokers, and two to never-smokers (27). For aMED, we divided all study participants into three groups on the basis of their aMED scores: zero was assigned to the lowest quartile of aMED score, one to quartiles 2 and 3, and two to quartile 4. For sleep duration, one was assigned to those with 6–8 hours of sleep per day and zero otherwise. The sum of the five individual scores constituted the overall combined lifestyle index score, ranging from 0 to 8, of which higher scores represented healthier lifestyle.

Ascertainment of HCC cases

Incident HCC cases and deaths were identified by annual linkage analysis of all surviving cohort participants with the national databases of the Singapore Cancer Registry and the Singapore Birth and Death Registry, respectively. The International Classification of Diseases-Oncology 2nd Edition Codes C22.0 were used to determine HCC cases (28). To date, only 56 (<0.1%) of the entire cohort participants are known to be lost to follow-up due to migration out of Singapore. Thus, the ascertainment of incident cancer cases and deaths among the cohort participants was virtually complete. As of December 2015, with an average 17.7 years of follow-up, 561 study participants developed HCC among 61,321 participants who were free of cancer at enrollment after excluding 1,936 participants with a history of cancer at baseline.

Case–control study of HCC

We also constructed a case–control study of HCC within the Singapore Chinese Health Study. All 197 incident HCC cases diagnosed before 31 December 2015 who donated a baseline blood sample were eligible for this study. For each case, we randomly selected 2–3 control subjects who donated a baseline blood sample and were alive and free of cancer at the date of diagnosis of the index case. Controls were individually matched to the index case by age at enrollment (±2 years old), gender, dialect groups (i.e., Hokkien and Cantonese), and date of baseline blood collection (± 6 months).

Serum samples of all subjects included in the case–control study of HCC were tested for serologic markers of HBV and HCV exposures using standard assays as described previously (9, 20, 29). The case/control status of the test samples was blinded to laboratory personnel. Briefly, the presence of hepatitis B surface antigen (HBsAg) was determined on the first 302 samples (80 cases vs. 222 controls) using a commercially available test kit (AUSRIA, Abbott Laboratories). Negative samples were further tested for the presence of antibodies to hepatitis core antigen (anti-HBc) and antibodies to hepatitis surface antigen (anti-HBs) using standardized test kit (Corab and Ausab, Abbott Laboratories). For the remaining 360 serum samples (117 cases vs. 243 controls), only the HBsAg status was determined using the same assay. We also tested for the presence of antibodies to the HCV (anti-HCV) on the first 302 samples (80 cases and 222 controls) using ELISA (version 2.0) Test Kit (Ortho Diagnostic System) and confirmation of positive samples was performed using RIBA (version 2.0) Test Kit (Chiron). Given the relatively low prevalence of anti-HCV in our study population (1.4%), we stopped testing anti-HCV for the remaining HCC cases and controls.

Statistical analysis

Means and SDs were calculated for continuous variables, while counts and proportions were computed for categorical variables. The t test and χ2 test were used to compare the distributions of continuous and categorical variables, respectively, between cases and noncases. ANOVA was used for the comparisons across different groups of the composite score of healthy lifestyle factors. Person-years at risk for each participant was calculated from the date of interview at entry into the cohort to the date of HCC diagnosis, death, migration out of Singapore, or 31 December 2015, whichever occurred first.

The Cox proportional hazard regression method was used to evaluate the association between the individual and composite score of healthy lifestyle factors and the risk of developing HCC. HRs and their corresponding 95% confidence intervals (CI) of HCC associated with higher individual and composite score of healthy lifestyle factors were derived from the Cox proportional hazard regression models. Proportional hazard assumption was tested using Schoenfeld residuals test, and no violation was found. An ordinal variable was used for the linear trend test for the index score of combined lifestyle factors and HCC risk. Potential confounders included in the multivariable Cox proportional hazards models were age, gender, dialect group (i.e., Hokkien or Cantonese), level of education (i.e., no formal education, primary school, secondary, or higher education), year of enrollment (i.e., 1993–1995 and 1996–1998), history of type 2 diabetes (yes vs. no), and total energy intake (Kcal/day). We also performed stratified analysis by gender and sensitivity analysis by excluding HCC cases and person-years observed within the first 2 years after the baseline interview. Additional sensitivity analyses were also performed for composite score of healthy lifestyle factors without sleep and aMED variables.

We used conditional logistic regression method in analysis for the entire dataset of the nested case–control study to evaluate the association between composite score of healthy lifestyle factors and the risk of HCC, with additional adjustment for HBsAg and anti-HCV serologic statuses. For those with missing anti-HCV (117 cases and 243 controls), a separate indicator variable was created and included in the logistic models. In the stratified analysis by HBsAg and anti-HCV statuses, unconditional logistic regression method was used with the inclusion of all matching factors (i.e., age, sex, dialect group, and year of enrollment) because the matched pairs were broken.

All statistical analyses were conducted using the computing software SAS version 9.4 (SAS Institute Inc.). All P values were two-sided and 0.05 was used as a threshold of statistical significance.

The mean (± SD) age at cancer diagnosis of the 561 HCC cases included in this study was 70.8 (± 8.4) years. The median time interval from the date of baseline interview to the diagnosis of HCC was 11.4 years (range, 0.03–22.2 years).

We observed lower proportions of secondary school or higher education and aMED score in quartile 4 among cases than noncases. However, there was no significant difference in sleep duration between HCC cases and noncases. Compared with those in the lowest composite score, those in the highest score were on average approximately 3 years younger at recruitment, and more likely to be women, to attain higher level of education, or to engage in physical exercise, but less likely to be Hokkien ethnic group and to have a history of diabetes (all P < 0.0001; Table 1). Among HCC cases, there were higher proportions of men, Hokkien ethnicity, BMI ≥ 23 kg/m2, cigarette smokers, alcohol drinkers with ≥7 drinks per week, aMED score in quartile 1, or those with a history of type 2 diabetes compared with non-HCC individuals (Supplementary Table S1).

Table 1.

Distributions of baseline characteristics among study participants by composite score of healthy lifestyle factors, the Singapore Chinese Health Study.

Composite score
CharacteristicsTotal participants, n0–345678P
Number of participants 61,321 922 2,960 10,218 20,427 20,694 6,100  
Mean age (± SD), years 56.4 ± 8.0 56.9 ± 7.7 58.7 ± 8.1 57.9 ± 8.1 56.9 ± 8.0 56.4 ± 7.8 54.1 ± 7.3 <0.0001 
Gender (%) 
 Male 27,293 (44.5) 837 (90.8) 2,237 (75.6) 6,411 (62.7) 3,443 (46.2) 6,567 (31.7) 1,798 (29.5) <0.0001 
 Female 34,028 (55.5) 85 (9.2) 723 (24.4) 3,807 (37.3) 10,984 (53.8) 14,127 (68.3) 4,302 (70.5)  
Dialect 
 Cantonese 28,325 (46.2) 320 (34.7) 1,151 (38.9) 4,196 (41.1) 9,034 (44.2) 10,191 (49.2) 3,433 (56.3) <0.0001 
 Hokkien 32,996 (53.8) 602 (65.3) 1,809 (61.1) 6,022 (58.9) 11,393 (55.8) 10,503 (50.7) 2,667 (43.7)  
Highest level of education (%) 
 No formal education 16,661 (27.2) 197 (21.4) 857 (28.9) 2,988 (29.2) 6,051 (29.6) 5,495 (26.5) 1,073 (17.6) <0.0001 
 Primary school 27,224 (44.4) 566 (60.3) 1,549 (52.3) 5,038 (49.3) 9,116 (44.6) 8,594 (41.5) 2,371 (38.9)  
 Secondary school or higher 17,436 (28.4) 168 (18.3) 554 (18.7) 2,192 (21.4) 5,260 (25.7) 6,605 (31.9) 2,656 (43.5)  
Diabetes (%) 
 No 55,852 (91.1) 833 (90.4) 2,643 (89.3) 9,136 (89.4) 18,500 (90.6) 19,087 (92.2) 5,053 (92.7) <0.0001 
 Yes 5,469 (8.9) 89 (9.6) 317 (10.7) 1,082 (10.6) 1,927 (9.4) 1,607 (7.8) 447 (7.3)  
Any weekly physical activity (%) 
 No 41,083 (67.0) 785 (85.1) 2,659 (89.8) 9,198 (90.0) 18,593 (91.0) 19,079 (92.2) 5,498 (90.1) <0.0001 
 Yes 20,238 (33.0) 137 (14.9) 301 (10.2) 1,020 (10.0) 1,834 (9.0) 1,615 (7.8) 602 (9.9)  
 Mean total energy intake (± SD), Kcal 1,556.6 ± 566.2 1,861.4 ± 730.0 1,530.7 ± 609.1 1,481.7 ± 573.7 1,505.9 ± 556.0 1,563.3 ± 537.3 1,796.1 ± 553.7 <0.0001 
Composite score
CharacteristicsTotal participants, n0–345678P
Number of participants 61,321 922 2,960 10,218 20,427 20,694 6,100  
Mean age (± SD), years 56.4 ± 8.0 56.9 ± 7.7 58.7 ± 8.1 57.9 ± 8.1 56.9 ± 8.0 56.4 ± 7.8 54.1 ± 7.3 <0.0001 
Gender (%) 
 Male 27,293 (44.5) 837 (90.8) 2,237 (75.6) 6,411 (62.7) 3,443 (46.2) 6,567 (31.7) 1,798 (29.5) <0.0001 
 Female 34,028 (55.5) 85 (9.2) 723 (24.4) 3,807 (37.3) 10,984 (53.8) 14,127 (68.3) 4,302 (70.5)  
Dialect 
 Cantonese 28,325 (46.2) 320 (34.7) 1,151 (38.9) 4,196 (41.1) 9,034 (44.2) 10,191 (49.2) 3,433 (56.3) <0.0001 
 Hokkien 32,996 (53.8) 602 (65.3) 1,809 (61.1) 6,022 (58.9) 11,393 (55.8) 10,503 (50.7) 2,667 (43.7)  
Highest level of education (%) 
 No formal education 16,661 (27.2) 197 (21.4) 857 (28.9) 2,988 (29.2) 6,051 (29.6) 5,495 (26.5) 1,073 (17.6) <0.0001 
 Primary school 27,224 (44.4) 566 (60.3) 1,549 (52.3) 5,038 (49.3) 9,116 (44.6) 8,594 (41.5) 2,371 (38.9)  
 Secondary school or higher 17,436 (28.4) 168 (18.3) 554 (18.7) 2,192 (21.4) 5,260 (25.7) 6,605 (31.9) 2,656 (43.5)  
Diabetes (%) 
 No 55,852 (91.1) 833 (90.4) 2,643 (89.3) 9,136 (89.4) 18,500 (90.6) 19,087 (92.2) 5,053 (92.7) <0.0001 
 Yes 5,469 (8.9) 89 (9.6) 317 (10.7) 1,082 (10.6) 1,927 (9.4) 1,607 (7.8) 447 (7.3)  
Any weekly physical activity (%) 
 No 41,083 (67.0) 785 (85.1) 2,659 (89.8) 9,198 (90.0) 18,593 (91.0) 19,079 (92.2) 5,498 (90.1) <0.0001 
 Yes 20,238 (33.0) 137 (14.9) 301 (10.2) 1,020 (10.0) 1,834 (9.0) 1,615 (7.8) 602 (9.9)  
 Mean total energy intake (± SD), Kcal 1,556.6 ± 566.2 1,861.4 ± 730.0 1,530.7 ± 609.1 1,481.7 ± 573.7 1,505.9 ± 556.0 1,563.3 ± 537.3 1,796.1 ± 553.7 <0.0001 

Significantly lower HR of HCC was associated with BMI < 23 kg/m2, never smoking, nonheavy drinking, or highest 25th percentile of aMED score. We combined light drinkers (≤14 drinks/week for men and ≤7 drinks/week for women) with nondrinkers due to their similar risk for HCC. Compared with heavy drinkers, HRs (95% CIs) for HCC in light drinkers and nondrinkers were 0.37 (0.24–0.57) and 0.42 (0.28–0.63), respectively. A daily sleep of 6–8 hours was associated with a statistically nonsignificant 10% decrease in risk of HCC (Table 2).

Table 2.

Association between individual lifestyle factors and risk of HCC in the Singapore Chinese Health Study.

Lifestyle factor (index score)%HCC incidence rate per 100,000 person-yearsaHRb (95% CI)
BMI, kg/m2 
 ≥23 (0) 52.1 61.59 1.00 
 <23 (1) 47.9 40.84 0.68 (0.58–0.81) 
Smoking statusc 
 Heavy smoker (0) 3.8 71.54 1.00 
 Light smoker (1) 26.8 68.01 0.74 (0.54–1.01) 
 Never smoker (2) 69.4 46.03 0.60 (0.43–0.83) 
Alcohol consumptiond 
 Heavy drinker (0) 1.6 86.61 1.00 
 Nonheavy drinker (2) 98.4 50.21 0.41 (0.28–0.61) 
aMED score 
 Quartile 1 (0) 21.1 61.85 1.00 
 Quartiles 2 and 3 (1) 59.4 52.10 0.88 (0.72–1.08) 
 Quartile 4 (2) 19.5 39.08 0.71 (0.53–0.96) 
Sleep duration (hours/day) 
 <6 or >8 (0) 16.5 60.41 1.00 
 6–8 (1) 83.5 50.25 0.90 (0.72–1.11) 
Lifestyle factor (index score)%HCC incidence rate per 100,000 person-yearsaHRb (95% CI)
BMI, kg/m2 
 ≥23 (0) 52.1 61.59 1.00 
 <23 (1) 47.9 40.84 0.68 (0.58–0.81) 
Smoking statusc 
 Heavy smoker (0) 3.8 71.54 1.00 
 Light smoker (1) 26.8 68.01 0.74 (0.54–1.01) 
 Never smoker (2) 69.4 46.03 0.60 (0.43–0.83) 
Alcohol consumptiond 
 Heavy drinker (0) 1.6 86.61 1.00 
 Nonheavy drinker (2) 98.4 50.21 0.41 (0.28–0.61) 
aMED score 
 Quartile 1 (0) 21.1 61.85 1.00 
 Quartiles 2 and 3 (1) 59.4 52.10 0.88 (0.72–1.08) 
 Quartile 4 (2) 19.5 39.08 0.71 (0.53–0.96) 
Sleep duration (hours/day) 
 <6 or >8 (0) 16.5 60.41 1.00 
 6–8 (1) 83.5 50.25 0.90 (0.72–1.11) 

aAdjusted for age and sex.

bHRs were derived from Cox proportional regression models that included all factors in the table simultaneously in addition to age, sex, dialect, year of enrollment, education level, diabetes status, and daily energy intake.

cHeavy smokers were those who started to smoke before 15 years of age and smoked 13 or more cigarettes per day, and light smokers were all remaining ever smokers.

dHeavy drinkers were defined as those who consumed ≥15 drinks/week for men and ≥8 drinks/week for women, following definitions from the U.S. Center for Disease Control and Prevention (https://www.cdc.gov/alcohol/pdfs/excessive_alcohol_use.pdf).

Higher composite score of the five healthy lifestyle factors was significantly associated with lower risk of HCC in a dose-dependent manner (Ptrend < 0.0001). Compared with the score of 0–4, the HRs (95% CIs) of HCC for those with the scores of 5, 6, 7, and 8 were 0.67 (0.52–0.85), 0.61 (0.48–0.77), 0.49 (0.37–0.65), and 0.13 (0.06–0.30), respectively, after adjustment for age, gender, history of diabetes, daily energy intake, and other potential confounders. The increment per composite score was associated with a statistically significant 22% reduction in risk of HCC. This inverse association was present consistently and comparable in both men and women (Table 3).

Table 3.

Association between composite score of healthy lifestyle factors and risk of HCC in the Singapore Chinese Health Study.

Composite scorePersonsPerson-yearsCasesHRa (95% CI)
Total participants 
 0–4 5,981 92,721 111 1.00 
 5 14,018 235,792 155 0.67 (0.52–0.85) 
 6 22,177 396,833 194 0.61 (0.48–0.77) 
 7 15,325 285,141 95 0.49 (0.37–0.65) 
 8 3,820 73,003 0.13 (0.06–0.30) 
Ptrend    <0.0001 
 Continuous scale    0.78 (0.72–0.83) 
Men 
 0–4 4,335 66,286 95 1.00 
 5 7,559 122,345 117 0.68 (0.52–0.89) 
 6 9,062 154,999 129 0.64 (0.49–0.83) 
 7 5,177 93,726 60 0.53 (0.38–0.74) 
 8 1,160 21,661 0.16 (0.06–0.43) 
Ptrend    <0.0001 
 Continuous scale    0.79 (0.73–0.86) 
Women 
 0–4 1,646 26,436 16 1.00 
 5 6,459 113,447 38 0.60 (0.33–1.07) 
 6 13,115 241,834 65 0.52 (0.30–0.90) 
 7 10,148 191,415 35 0.38 (0.20–0.70) 
 8 2,660 51,342 0.09 (0.02–0.38) 
Ptrend    0.0003 
 Continuous scale    0.72 (0.61–0.84) 
Pheterogeneity    0.51 
Composite scorePersonsPerson-yearsCasesHRa (95% CI)
Total participants 
 0–4 5,981 92,721 111 1.00 
 5 14,018 235,792 155 0.67 (0.52–0.85) 
 6 22,177 396,833 194 0.61 (0.48–0.77) 
 7 15,325 285,141 95 0.49 (0.37–0.65) 
 8 3,820 73,003 0.13 (0.06–0.30) 
Ptrend    <0.0001 
 Continuous scale    0.78 (0.72–0.83) 
Men 
 0–4 4,335 66,286 95 1.00 
 5 7,559 122,345 117 0.68 (0.52–0.89) 
 6 9,062 154,999 129 0.64 (0.49–0.83) 
 7 5,177 93,726 60 0.53 (0.38–0.74) 
 8 1,160 21,661 0.16 (0.06–0.43) 
Ptrend    <0.0001 
 Continuous scale    0.79 (0.73–0.86) 
Women 
 0–4 1,646 26,436 16 1.00 
 5 6,459 113,447 38 0.60 (0.33–1.07) 
 6 13,115 241,834 65 0.52 (0.30–0.90) 
 7 10,148 191,415 35 0.38 (0.20–0.70) 
 8 2,660 51,342 0.09 (0.02–0.38) 
Ptrend    0.0003 
 Continuous scale    0.72 (0.61–0.84) 
Pheterogeneity    0.51 

Note: Boldface indicates P < 0.05.

aHRs were derived from Cox proportional regression models that also included age, sex, dialect, year of enrollment, education level, diabetes status, and daily energy intake.

We determined HBsAg status for 197 HCC cases and 465 matched controls. In addition, 80 HCC cases and 222 controls also were tested for anti-HCV status. Among tested HCC cases, 41.3% were positive for HBsAg and 5% were positive for anti-HCV. The corresponding figures in controls were 3.2% and 1.4%.

In the case–control analysis, with additional adjustment for chronic infection with HBV and/or HCV, we found a similar inverse association between the composite score of healthy lifestyle factors and HCC risk overall (Table 4). Among HBsAg-negative and anti-HCV–negative/unknown subjects, HR of HCC decreased by more than 60% for those with the highest composite score compared with the lowest score category of healthy lifestyle factors (OR, 0.38; 95% CI, 0.19–0.79; Ptrend = 0.001). Given the small sample size for HBsAg- or anti-HCV–positive individuals, the risk estimates for HCC associated with composite score of healthy lifestyle factors varied greatly and were not informative (Table 4).

Table 4.

Association between composite score of healthy lifestyle factors and risk of HCC stratified by hepatitis B and/or hepatitis C viral serology in the Singapore Chinese Health Study.

Composite scoreCaseControlOR (95% CI)
All participantsa,b 
 0–4 32 54 1.00 
 5 44 119 0.58 (0.30–1.12) 
 6 78 163 0.70 (0.37–1.30) 
 7 41 101 0.46 (0.22–0.94) 
 8 28 0.04 (0.01–0.23) 
Ptrend   0.003 
 Continuous scale   0.75 (0.62–0.90) 
HBsAg-negative and anti-HCV–negative participantsc,d 
 0–4 24 51 1.00 
 5 32 114 0.53 (0.28–1.00) 
 6 47 157 0.53 (0.28–0.98) 
 7 20 97 0.38 (0.19–0.79) 
 8 24  
Ptrend   0.001 
 Continuous scale   0.73 (0.60–0.88) 
HBsAg-positive or anti-HCV–positive participantsc,d 
 0–4 1.00 
 5 12 1.10 (0.19–6.42) 
 6 31 2.22 (0.41–11.89) 
 7 21 2.46 (0.37–16.49) 
 8 0.22 (0.02–2.19) 
Ptrend   0.77 
 Continuous scale   0.93 (0.60–1.46) 
Pheterogeneity   0.884 
Composite scoreCaseControlOR (95% CI)
All participantsa,b 
 0–4 32 54 1.00 
 5 44 119 0.58 (0.30–1.12) 
 6 78 163 0.70 (0.37–1.30) 
 7 41 101 0.46 (0.22–0.94) 
 8 28 0.04 (0.01–0.23) 
Ptrend   0.003 
 Continuous scale   0.75 (0.62–0.90) 
HBsAg-negative and anti-HCV–negative participantsc,d 
 0–4 24 51 1.00 
 5 32 114 0.53 (0.28–1.00) 
 6 47 157 0.53 (0.28–0.98) 
 7 20 97 0.38 (0.19–0.79) 
 8 24  
Ptrend   0.001 
 Continuous scale   0.73 (0.60–0.88) 
HBsAg-positive or anti-HCV–positive participantsc,d 
 0–4 1.00 
 5 12 1.10 (0.19–6.42) 
 6 31 2.22 (0.41–11.89) 
 7 21 2.46 (0.37–16.49) 
 8 0.22 (0.02–2.19) 
Ptrend   0.77 
 Continuous scale   0.93 (0.60–1.46) 
Pheterogeneity   0.884 

Note: Boldface indicates P < 0.05.

aORs were derived from conditional logistic regression models that also included level of education, diabetes status, dietary energy intake, and seropositivity of HBsAg and/or anti-HCV. A separate indicator variable for 117 HCC cases and 243 controls with unknown anti-HCV status was included in the logistic model.

bConditional logistic regression model was performed.

cORs were derived from conditional logistic regression models that also included age, gender, dialect group, level of education, year of enrollment, diabetes status, and dietary calorie intake.

dUnconditional logistic regression model was performed.

We conducted several sensitivity analyses. First, we excluded HCC cases and person-years within the first 2 years of observation and found that the results were similar as those based on the entire cohort. Compared with the composite score of 0–4, the multivariable-adjusted HRs (95% CIs) of HCC for the composite scores of 5, 6, 7, and 8 were 0.66 (0.51–0.85), 0.62 (0.48–0.79), 0.50 (0.37–0.62), and 0.14 (0.06–0.32), respectively (Ptrend < 0.0001; Supplementary Table S2). Then, we excluded sleep duration from the composite score because it alone was not statistically significantly associated with HCC risk (Table 2). The association between the composite score without sleep duration and HCC risk weakened, but remained statistically significant; HRs (95% CIs) for new scores 5, 6, and 7 were 0.65 (0.53–0.80), 0.57 (0.45–0.71), and 0.28 (0.17–0.43), respectively, compared with new score 0–4 (Ptrend < 0.0001). We also conducted similar analysis by removing aMED from the composite score and yielded similar inverse, but weakened association; HRs (95% CIs) for scores 5 and 6 were 0.62 (0.51–0.76) and 0.46 (0.36–0.58), respectively, compared with score 0–4 (Ptrend < 0.0001).

Stratified analyses were performed to assess the heterogeneity in the composite score–HCC risk association by selected factors, including diabetes status and BMI. The association between the composite score and HCC was more apparent in participants without history of diabetes (Ptrend < 0.0001) than in those with history of diabetes (Ptrend = 0.0005); however, the difference between the two was not statistically significant (Pheterogeneity = 0.278). The association was more apparent in participants with BMI < 23 kg/m2 (Ptrend < 0.0001) than in those with BMI ≥ 23 kg/m2 (Ptrend = 0.06), with a statistical significance (Pheterogeneity = 0.004) in heterogeneity between the two subgroups (Supplementary Table S3).

In this analysis, in a population-based prospective cohort study of more than 60,000 individuals with an average follow-up of 17.7 years, we found that higher composite score of healthy lifestyle factors, including BMI, smoking, alcohol consumption, Mediterranean-style diet, and sleep duration, was associated with decreased risk of HCC in a dose-dependent manner. This inverse relationship was robust and present in both men and women and in those with at least 2 or more years of follow-up. The observed inverse association was confirmed among individuals with negative HBsAg and negative anti-HCV, suggesting that the effect of these lifestyle factors on HCC risk was independent of chronic infection with HBV and HCV, major risk factors for HCC.

This study showed lower risk of HCC for individuals who adhered to a healthier lifestyle, including adhering to heathier diet based on Mediterranean dietary habits (i.e., eating more vegetables, fruit, and nuts/legumes, and fish and fatty foods), maintaining a normal range of BMI, moderate or no alcohol consumption, never smoking cigarettes, and regular sleep duration of 6–8 hours a day. Compared with the lowest score, individuals with the highest composite score of healthy lifestyle factors had reduced by 85% in the risk of developing HCC overall, and by 90% in those without chronic infection with HBV.

Previously, we reported an inverse association between a similarly constructed composite score of healthy lifestyle factors and risk of colon and gastric cancers (30, 31). Accordingly, Odegaard and colleagues (30) found that this same composite score was significantly associated with lower risk of colon cancer, but not with risk of rectal cancer. A similar inverse association was observed for gastric cancer in our study population (31).

Several prior studies provide supportive evidence for an inverse association between the individual healthy lifestyle factors and HCC risk. A meta-analysis including 26 prospective cohort studies with a total of 9 million study participants, including 16 Asian studies, four U.S. studies, and six European studies, showed that both overweight and obesity were associated with higher risk of primary liver cancer (32). Recently, an analysis on registry data of more than 1.2 million Swedish men enlisted for conscription between 1969 and 1996 reported that overweight and obese men were at higher risk of severe liver disease (i.e., end-stage liver disease, HCC, or death from any liver disease) or gallbladder or bile duct carcinoma (33). Obesity is an underlying cause for the development and progression of NAFLD, which includes nonalcoholic steatohepatitis and cirrhosis, a precondition for HCC (4).

Alcohol abuse is an important risk factor for HCC. A recent meta-analysis of 19 prospective cohort studies from Asia (15 cohorts), Europe (two cohorts), and the United States (two cohorts) showed that the pooled RRs were 0.91 (95% CI, 0.81–1.02) for moderate drinking (1–2 drinks/day) and 1.16 (95% CI, 1.01–1.34) for heavy drinking (≥3 drinks/day) compared with nondrinking (34). Excessive alcohol consumption, potentially via carcinogenicity of acetaldehyde, the first metabolite of alcohol (35), is associated with alcoholic cirrhosis, which increases the risk of HCC (36). However, the association between moderate drinking and HCC risk is inconsistent. Our study showed that non- or moderate drinkers (≤14 drinks/week for male or ≤7 drinks/week for female) had a statistically significant 59% lower risk of HCC than heavy drinkers. Among non-Asians in Los Angeles, we have previously reported that there was no increased risk of HCC for consumption of 1–4 drinks per day (37). There may be different alcohol threshold for risk of HCC among different race/ethnic groups, especially at the lower end of the alcohol consumption level with the risk of HCC in Asian compared with non-Asian populations. More studies are warranted to clarify this observation.

Cigarette smoking has also been reported as an independent risk factor for HCC. In a meta-analysis of 38 cohort studies and 58 case–control studies, Lee and colleagues (38) reported that the adjusted pooled RR estimates were 1.51 (95% CI, 1.37–1.67) for current smokers and 1.12 (95% CI, 0.78–1.60) for former smokers compared with never smokers. Our results are consistent with these previous studies (38). Tobacco smoke contains a myriad of chemical compounds that are carcinogenic or toxic to the liver (39). For example, N-nitrosodimethylamine, which is abundant in cigarette smoke, can induce liver tumor in rodents (40).

aMED was found to be associated with lower risk of HCC across different populations. In the United States, four prospective cohort studies (41–43), all reported an inverse association between aMED and risk of HCC, with a 25%–39% lower risk of HCC with highest adherence to aMED. These results are consistent with our findings (i.e., 22% risk reduction of HCC for the highest quartile compared with the lowest quartile), as shown in Table 2.

Recent studies have demonstrated an association between sleep duration and the risk of liver cancer (10) or NAFLD (11, 12). Mechanistically, the circadian clock is believed to play a role in mitochondrial dysfunction (44) and in the regulation of hepatic triglyceride accumulation, oxidative stress, and inflammation (45); all of which may contribute to the development and progression of NAFLD. In wild-type mice, chronic circadian misalignment led to the disruption of circadian clock and induced spontaneous NAFLD-related HCC independent of dietary exposure, exogenous genotoxic stress, and/or germline gene mutation (46).

Strengths of this study include prospective study design, a comprehensive questionnaire collecting multiple lifestyle factors and detailed dietary information before the HCC occurrence, large sample size allowing for robust estimates of HCC risk, use of a composite score of healthy lifestyle factors that comprehensively characterized an individual person's profile, long-term and nearly complete follow-up that reduced potential bias due to loss of follow-up or the reverse impact of disease on the exposure–HCC risk association, and known HBsAg and anti-HCV serology on a sizable subset of HCC cases and the controls presenting the entire cohort. This robust study design allowed us to examine these lifestyle factors on HCC risk among HBsAg-negative and anti-HCV–positive individuals only, which ruled out the potential confounding effect of both HBV and HCV infections on the observed association.

One potential limitation of our study was the misclassification of lifestyle factors because their assessment at baseline might not reflect the level of long-term exposure due to the change of lifestyle after baseline assessment. As in any observational study, such misclassification is usually nondifferential to both HCC cases and non-HCC participants. Nondifferential misclassification usually results in the underestimation of HRs toward null. Thus, the significant association between composite score of healthy lifestyle factors and HCC risk observed in this study may be underestimated, but the conclusion is valid.

In summary, this study shows a strong, dose-dependent association between the composite score of healthy lifestyle factors and lower risk of HCC development. The overall results, especially among HBsAg-negative and anti-HCV–negative individuals, support the development of a prevention strategy including multiple lifestyle factors that would result in significant reduction in HCC incidence in general populations. This finding highlights the importance of promoting healthy living for primary prevention of HCC, even in a population with a relatively high prevalence of HBV infection and high background risk of HCC. Our findings are pertinent to the populations in the United States and other populations where nonviral factors are projected to have increasingly greater impact on HCC incidence and mortality.

J.-M. Yuan reports grants from NIH during the conduct of the study. No disclosures were reported by the other authors.

H.N. Luu: Conceptualization, formal analysis, supervision, validation, investigation, methodology, writing–original draft, writing–review and editing. J. Behari: Formal analysis, investigation, methodology, writing–review and editing. G.B.-B. Goh: Investigation, methodology, writing–review and editing. R. Wang: Data curation, software, formal analysis, validation, writing–review and editing. A. Jin: Data curation, software, formal analysis, validation. C.E. Thomas: Software, formal analysis, writing–review and editing. J.C. Clemente: Investigation, methodology, writing–review and editing. A.O. Odegaard: Validation, methodology, writing–review and editing. W.-P. Koh: Conceptualization, resources, formal analysis, supervision, validation, methodology, writing–review and editing. J.-M. Yuan: Conceptualization, resources, formal analysis, supervision, funding acquisition, investigation, methodology, project administration, writing–review and editing.

The authors thank Siew-Hong Low of the National University of Singapore for supervising the field work of the Singapore Chinese Health Study. They also thank the Singapore Cancer Registry for the identification of incident cancer cases among participants of the Singapore Chinese Health Study. The Singapore Chinese Health Study was supported by the NIH (grant nos. R01 CA144034 and UM1 CA182876). W.-P. Koh was supported by the National Medical Research Council, Singapore (NMRC/CSA/0055/2013). H.N. Luu was partially supported by the University of Pittsburgh Medical Center Hillman Cancer Center start-up grant.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1.
Bray
F
,
Ferlay
J
,
Soerjomataram
I
,
Siegel
RL
,
Torre
LA
,
Jemal
A
. 
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
.
CA Cancer J Clin
2018
;
68
:
394
424
.
2.
El-Serag
HB
,
Rudolph
KL
. 
Hepatocellular carcinoma: epidemiology and molecular carcinogenesis
.
Gastroenterology
2007
;
132
:
2557
76
.
3.
Yu
MC
,
Yuan
J-M
. 
Environmental factors and risk for hepatocellular carcinoma
.
Gastroenterology
2004
;
127
:
S72
78
.
4.
Anstee
QM
,
Reeves
HL
,
Kotsiliti
E
,
Govaere
O
,
Heikenwalder
M
. 
From NASH to HCC: current concepts and future challenges
.
Nat Rev Gastroenterol Hepatol
2019
;
16
:
411
28
.
6.
Noone
A
,
Howlader
N
,
Krapcho
M
,
Miller
D
,
Brest
A
,
Yu
M
, et al
SEER cancer statistics review, 1975–2015, National Cancer Institute
.
Available from:
https://seer.cancer.gov/csr/1975_2015/.
7.
Petrick
JL
,
McGlynn
KA
. 
The changing epidemiology of primary liver cancer
.
Curr Epidemiol Rep
2019
;
6
:
104
11
.
8.
Fujiwara
N
,
Friedman
SL
,
Goossens
N
,
Hoshida
Y
. 
Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine
.
J Hepatol
2018
;
68
:
526
49
.
9.
Koh
W-P
,
Robien
K
,
Wang
R
,
Govindarajan
S
,
Yuan
J-M
,
Yu
MC
. 
Smoking as an independent risk factor for hepatocellular carcinoma: the Singapore Chinese Health Study
.
Br J Cancer
2011
;
105
:
1430
5
.
10.
Royse
KE
,
El-Serag
HB
,
Chen
L
,
White
DL
,
Hale
L
,
Sangi-Haghpeykar
H
, et al
Sleep duration and risk of liver cancer in postmenopausal women: the Women's Health Initiative Study
.
J Womens Health
2017
;
26
:
1270
7
.
11.
Kim
D
,
Kim
HJ
,
Kushida
CA
,
Heo
N-Y
,
Ahmed
A
,
Kim
WR
. 
Short sleep duration is associated with abnormal serum aminotransferase activities and nonalcoholic fatty liver disease
.
Clin Gastroenterol Hepatol
2018
;
16
:
588
90
.
12.
Kim
C-W
,
Yun
KE
,
Jung
H-S
,
Chang
Y
,
Choi
E-S
,
Kwon
M-J
, et al
Sleep duration and quality in relation to non-alcoholic fatty liver disease in middle-aged workers and their spouses
.
J Hepatol
2013
;
59
:
351
7
.
13.
Yuan
J-M
,
Stram
DO
,
Arakawa
K
,
Lee
H-P
,
Yu
MC
. 
Dietary cryptoxanthin and reduced risk of lung cancer: the Singapore Chinese Health Study
.
Cancer Epidemiol Biomark Prev
2003
;
12
:
890
8
.
14.
Koh
W-P
,
Yuan
J-M
,
Sun
C-L
,
Lee
H-P
,
Yu
MC
. 
Middle-aged and older Chinese men and women in Singapore who smoke have less healthy diets and lifestyles than nonsmokers
.
J Nutr
2005
;
135
:
2473
7
.
15.
Eaglehouse
YL
,
Koh
W-P
,
Wang
R
,
Aizhen
J
,
Yuan
J-M
,
Butler
LM
. 
Physical activity, sedentary time, and risk of colorectal cancer: the Singapore Chinese Health Study
.
Eur J Cancer Prev
2017
;
26
:
469
75
.
16.
Hankin
JH
,
Stram
DO
,
Arakawa
K
,
Park
S
,
Low
SH
,
Lee
HP
, et al
Singapore Chinese Health Study: development, validation, and calibration of the quantitative food frequency questionnaire
.
Nutr Cancer
2001
;
39
:
187
95
.
17.
Seow
A
,
Shi
CY
,
Franke
AA
,
Hankin
JH
,
Lee
HP
,
Yu
MC
. 
Isoflavonoid levels in spot urine are associated with frequency of dietary soy intake in a population-based sample of middle-aged and older Chinese in Singapore
.
Cancer Epidemiol Biomark Prev
1998
;
7
:
135
40
.
18.
Seow
A
,
Shi
CY
,
Chung
FL
,
Jiao
D
,
Hankin
JH
,
Lee
HP
, et al
Urinary total isothiocyanate (ITC) in a population-based sample of middle-aged and older Chinese in Singapore: relationship with dietary total ITC and glutathione S-transferase M1/T1/P1 genotypes
.
Cancer Epidemiol Biomark Prev
1998
;
7
:
775
81
.
19.
Koh
W-P
,
Dan
YY
,
Goh
GB-B
,
Jin
A
,
Wang
R
,
Yuan
J-M
. 
Dietary fatty acids and risk of hepatocellular carcinoma in the Singapore Chinese Health Study
.
Liver Int
2016
;
36
:
893
901
.
20.
Johnson
S
,
Koh
W-P
,
Wang
R
,
Govindarajan
S
,
Yu
MC
,
Yuan
J-M
. 
Coffee consumption and reduced risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study
.
Cancer Causes Control CCC
2011
;
22
:
503
10
.
21.
U.S. Department of Agriculture (USDA)
.
Agriculture handbook
.
Washington, DC
:
U.S. Department of Agriculture (USDA)
; 
2002
.
22.
Trichopoulou
A
,
Kouris-Blazos
A
,
Wahlqvist
ML
,
Gnardellis
C
,
Lagiou
P
,
Polychronopoulos
E
, et al
Diet and overall survival in elderly people
.
BMJ
1995
;
311
:
1457
60
.
23.
Trichopoulou
A
,
Costacou
T
,
Bamia
C
,
Trichopoulos
D
. 
Adherence to a Mediterranean diet and survival in a Greek population
.
N Engl J Med
2003
;
348
:
2599
608
.
24.
Fung
TT
,
Hu
FB
,
McCullough
ML
,
Newby
PK
,
Willett
WC
,
Holmes
MD
. 
Diet quality is associated with the risk of estrogen receptor-negative breast cancer in postmenopausal women
.
J Nutr
2006
;
136
:
466
72
.
25.
WHO Expert Consultation
. 
Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies
.
Lancet
2004
;
363
:
157
63
.
26.
Pan
W-H
,
Yeh
W-T
. 
How to define obesity? Evidence-based multiple action points for public awareness, screening, and treatment: an extension of Asian-Pacific recommendations
.
Asia Pac J Clin Nutr
2008
;
17
:
370
4
.
27.
Tsong
WH
,
Koh
W-P
,
Yuan
J-M
,
Wang
R
,
Sun
C-L
,
Yu
MC
. 
Cigarettes and alcohol in relation to colorectal cancer: the Singapore Chinese Health Study
.
Br J Cancer
2007
;
96
:
821
7
.
28.
Parkin
DM
,
Whelan
S
,
Ferlay
J
,
Teppo
L
,
Thomas
D
, editors.
Cancer incidence in five continents
.
Lyon, France
:
IARC Press
; 
2002.
29.
Nieters
A
,
Yuan
J-M
,
Sun
C-L
,
Zhang
Z-Q
,
Stoehlmacher
J
,
Govindarajan
S
, et al
Effect of cytokine genotypes on the hepatitis B virus-hepatocellular carcinoma association
.
Cancer
2005
;
103
:
740
8
.
30.
Odegaard
AO
,
Koh
W-P
,
Yuan
J-M
. 
Combined lifestyle factors and risk of incident colorectal cancer in a Chinese population
.
Cancer Prev Res Phila Pa
2013
;
6
:
360
7
.
31.
Wang
Z
,
Koh
W-P
,
Jin
A
,
Wang
R
,
Yuan
J-M
. 
Composite protective lifestyle factors and risk of developing gastric adenocarcinoma: the Singapore Chinese Health Study
.
Br J Cancer
2017
;
116
:
679
87
.
32.
Chen
Y
,
Wang
X
,
Wang
J
,
Yan
Z
,
Luo
J
. 
Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies
.
Eur J Cancer Oxf Engl 1990
2012
;
48
:
2137
45
.
33.
Hagström
H
,
Tynelius
P
,
Rasmussen
F
. 
High BMI in late adolescence predicts future severe liver disease and hepatocellular carcinoma: a national, population-based cohort study in 1.2 million men
.
Gut
2018
;
67
:
1536
42
.
34.
Turati
F
,
Galeone
C
,
Rota
M
,
Pelucchi
C
,
Negri
E
,
Bagnardi
V
, et al
Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies
.
Ann Oncol
2014
;
25
:
1526
35
.
35.
International Agency for Research on Cancer
.
Monographs on the evaluation of carcinogenic risks to humans. Alcohol consumption and ethyl carbamate
.
Lyon, France
:
International Agency for Research on Cancer, WHO
; 
2010
.
Available from
: https://publications.iarc.fr/Book-And-Report-Series/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans/Alcohol-Consumption-And-Ethyl-Carbamate-2010.
36.
La Vecchia
C
,
Negri
E
,
Cavalieri d'Oro
L
,
Franceschi
S
. 
Liver cirrhosis and the risk of primary liver cancer
.
Eur J Cancer Prev
1998
;
7
:
315
20
.
37.
Yuan
J-M
,
Govindarajan
S
,
Arakawa
K
,
Yu
MC
. 
Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S
.
Cancer
2004
;
101
:
1009
17
.
38.
Lee
Y-CA
,
Cohet
C
,
Yang
Y-C
,
Stayner
L
,
Hashibe
M
,
Straif
K
. 
Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer
.
Int J Epidemiol
2009
;
38
:
1497
511
.
39.
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Tobacco smoke and involuntary smoking
.
IARC Monogr Eval Carcinog Risks Hum.
2004
;
83
:
1
1438
.
40.
International Agency for Research on Cancer
.
Monographs on the evaluation of carcinogenic risks to humans. Some N-notroso compounds
.
Lyon
,
France
:
International Agency for Research on Cancer
; 
1978
.
41.
Ma
Y
,
Yang
W
,
Simon
TG
,
Smith-Warner
SA
,
Fung
TT
,
Sui
J
, et al
Dietary patterns and risk of hepatocellular carcinoma among U.S. men and women
.
Hepatology
2019
;
70
:
577
86
.
42.
Li
W-Q
,
Park
Y
,
McGlynn
KA
,
Hollenbeck
AR
,
Taylor
PR
,
Goldstein
AM
, et al
Index-based dietary patterns and risk of incident hepatocellular carcinoma and mortality from chronic liver disease in a prospective study
.
Hepatology
2014
;
60
:
588
97
.
43.
Bogumil
D
,
Park
S-Y
,
Le Marchand
L
,
Haiman
CA
,
Wilkens
LR
,
Boushey
CJ
, et al
High-quality diets are associated with reduced risk of hepatocellular carcinoma and chronic liver disease: the multiethnic cohort
.
Hepatol Commun
2019
;
3
:
437
47
.
44.
Jacobi
D
,
Liu
S
,
Burkewitz
K
,
Kory
N
,
Knudsen
NH
,
Alexander
RK
, et al
Hepatic bmal1 regulates rhythmic mitochondrial dynamics and promotes metabolic fitness
.
Cell Metab
2015
;
22
:
709
20
.
45.
Adamovich
Y
,
Rousso-Noori
L
,
Zwighaft
Z
,
Neufeld-Cohen
A
,
Golik
M
,
Kraut-Cohen
J
, et al
Circadian clocks and feeding time regulate the oscillations and levels of hepatic triglycerides
.
Cell Metab
2014
;
19
:
319
30
.
46.
Kettner
NM
,
Voicu
H
,
Finegold
MJ
,
Coarfa
C
,
Sreekumar
A
,
Putluri
N
, et al
Circadian homeostasis of liver metabolism suppresses hepatocarcinogenesis
.
Cancer Cell
2016
;
30
:
909
24
.